nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—prostate gland—prostate cancer	0.0119	0.224	CbGeAlD
Gadopentetate dimeglumine—PGD—seminal vesicle—prostate cancer	0.01	0.189	CbGeAlD
Gadopentetate dimeglumine—PGD—renal system—prostate cancer	0.00809	0.152	CbGeAlD
Gadopentetate dimeglumine—PGD—urethra—prostate cancer	0.00795	0.15	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—prostate cancer	0.00612	0.115	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—CBR1—prostate cancer	0.00584	0.0435	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—testis—prostate cancer	0.00523	0.0985	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM3—prostate cancer	0.0051	0.038	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC39A1—prostate cancer	0.00462	0.0344	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—lymph node—prostate cancer	0.00379	0.0714	CbGeAlD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PGAM2—prostate cancer	0.00323	0.024	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—NAGLU—prostate cancer	0.00323	0.024	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA3—prostate cancer	0.00312	0.0232	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA4—prostate cancer	0.00285	0.0212	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA2—prostate cancer	0.00278	0.0207	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA1—prostate cancer	0.00268	0.02	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—B4GALT4—prostate cancer	0.0026	0.0194	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HSP90AB1—prostate cancer	0.00259	0.0193	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—NFE2L2—prostate cancer	0.00236	0.0176	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GPX3—prostate cancer	0.00225	0.0168	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFA—prostate cancer	0.00225	0.0168	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—CYP2A6—prostate cancer	0.00203	0.0151	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A5—prostate cancer	0.00177	0.0132	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—NQO1—prostate cancer	0.00171	0.0127	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HSPA1A—prostate cancer	0.0017	0.0126	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—EGR1—prostate cancer	0.00159	0.0118	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GGT1—prostate cancer	0.00159	0.0118	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—RXRA—prostate cancer	0.00149	0.0111	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFBR2—prostate cancer	0.00142	0.0106	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTP1—prostate cancer	0.00142	0.0106	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM1—prostate cancer	0.00131	0.00976	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—PRKACB—prostate cancer	0.00124	0.00926	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HAO1—prostate cancer	0.00107	0.00801	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SV2B—prostate cancer	0.000972	0.00724	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NAGLU—prostate cancer	0.000914	0.00681	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AOX1—prostate cancer	0.000914	0.00681	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RFK—prostate cancer	0.000914	0.00681	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PGAM2—prostate cancer	0.000914	0.00681	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ADI1—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PSAT1—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TST—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CBR1—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GRHL1—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CSAD—prostate cancer	0.000876	0.00653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CTBP2—prostate cancer	0.000827	0.00616	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—DNAJC3—prostate cancer	0.000827	0.00616	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HSD17B1—prostate cancer	0.000827	0.00616	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UGT2B15—prostate cancer	0.000814	0.00607	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UGT2B17—prostate cancer	0.000814	0.00607	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CKMT2—prostate cancer	0.000814	0.00607	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GRHPR—prostate cancer	0.000814	0.00607	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PGAM2—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NAGLU—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SULT2B1—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MBTPS1—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—RFK—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM3—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AOX1—prostate cancer	0.000766	0.0057	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL17RD—prostate cancer	0.000737	0.00549	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—B4GALT4—prostate cancer	0.000737	0.00549	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP3A43—prostate cancer	0.000726	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AMACR—prostate cancer	0.000726	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NAT1—prostate cancer	0.000726	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SRD5A2—prostate cancer	0.000726	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—DEGS1—prostate cancer	0.000726	0.00541	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD17B1—prostate cancer	0.000692	0.00516	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WNT4—prostate cancer	0.000657	0.00489	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—B4GALT4—prostate cancer	0.000617	0.0046	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HPGD—prostate cancer	0.000617	0.0046	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LDHB—prostate cancer	0.000589	0.00439	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL12—prostate cancer	0.000589	0.00439	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TNFRSF21—prostate cancer	0.00058	0.00432	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP7B1—prostate cancer	0.000564	0.00421	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MTAP—prostate cancer	0.000564	0.00421	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TCN2—prostate cancer	0.000558	0.00416	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SRD5A1—prostate cancer	0.00055	0.0041	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SULT1E1—prostate cancer	0.00055	0.0041	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFB1—prostate cancer	0.000534	0.00398	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD17B3—prostate cancer	0.000525	0.00391	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACSL4—prostate cancer	0.000525	0.00391	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ARG2—prostate cancer	0.000503	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UMPS—prostate cancer	0.000503	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PHGDH—prostate cancer	0.000503	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LDHB—prostate cancer	0.000493	0.00368	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP3A5—prostate cancer	0.000484	0.00361	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GSTO1—prostate cancer	0.000475	0.00354	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PDHA1—prostate cancer	0.000468	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UCP3—prostate cancer	0.000468	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TCN2—prostate cancer	0.000468	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA3—prostate cancer	0.000468	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LRP2—prostate cancer	0.000455	0.00339	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EIF2AK2—prostate cancer	0.000446	0.00333	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—P4HB—prostate cancer	0.000446	0.00333	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL10—prostate cancer	0.000446	0.00333	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD3B1—prostate cancer	0.000446	0.00332	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC22A3—prostate cancer	0.000446	0.00332	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIST1H2BG—prostate cancer	0.000438	0.00327	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TBXAS1—prostate cancer	0.000428	0.00319	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA4—prostate cancer	0.000428	0.00319	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIST1H4H—prostate cancer	0.000423	0.00315	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NPPA—prostate cancer	0.000423	0.00315	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA2—prostate cancer	0.000417	0.00311	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SULT1A1—prostate cancer	0.000412	0.00307	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCG5—prostate cancer	0.000412	0.00307	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA1—prostate cancer	0.000402	0.003	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSD3B2—prostate cancer	0.000398	0.00296	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTO1—prostate cancer	0.000398	0.00296	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NAT2—prostate cancer	0.000398	0.00296	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLCB2—prostate cancer	0.000381	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2C18—prostate cancer	0.000381	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LRP2—prostate cancer	0.000381	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—P4HB—prostate cancer	0.000374	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC22A1—prostate cancer	0.000364	0.00271	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFBR1—prostate cancer	0.00036	0.00268	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—B2M—prostate cancer	0.00036	0.00268	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SULT2A1—prostate cancer	0.000354	0.00264	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKR1C3—prostate cancer	0.000354	0.00264	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS19—prostate cancer	0.000354	0.00264	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PRKACB—prostate cancer	0.000352	0.00262	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MED12—prostate cancer	0.000349	0.0026	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GNG5—prostate cancer	0.000346	0.00258	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PPP3CA—prostate cancer	0.000343	0.00256	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA3—prostate cancer	0.000333	0.00248	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PRKCZ—prostate cancer	0.000332	0.00247	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CALR—prostate cancer	0.000326	0.00243	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGFR4—prostate cancer	0.000321	0.00239	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PARP1—prostate cancer	0.000321	0.00239	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HPGDS—prostate cancer	0.000318	0.00237	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CALCA—prostate cancer	0.000317	0.00236	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2C19—prostate cancer	0.000316	0.00235	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTT1—prostate cancer	0.000308	0.0023	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACHE—prostate cancer	0.000308	0.0023	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2A6—prostate cancer	0.000305	0.00227	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HSPA1A—prostate cancer	0.000304	0.00226	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKR1C3—prostate cancer	0.000297	0.00221	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PRKACB—prostate cancer	0.000295	0.0022	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP17A1—prostate cancer	0.000292	0.00217	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CASP9—prostate cancer	0.000291	0.00217	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PRKCQ—prostate cancer	0.000282	0.0021	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA2—prostate cancer	0.000278	0.00207	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF10—prostate cancer	0.000268	0.002	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A5—prostate cancer	0.000265	0.00198	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2E1—prostate cancer	0.000259	0.00193	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NQO1—prostate cancer	0.000256	0.00191	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFBR2—prostate cancer	0.000255	0.0019	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TH—prostate cancer	0.000253	0.00188	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ITPR1—prostate cancer	0.000251	0.00187	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP3A4—prostate cancer	0.00025	0.00186	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1B1—prostate cancer	0.000246	0.00183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GGT1—prostate cancer	0.000238	0.00177	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA1—prostate cancer	0.000234	0.00175	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP19A1—prostate cancer	0.000231	0.00172	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LPL—prostate cancer	0.00023	0.00172	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PDGFRB—prostate cancer	0.000228	0.0017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—RXRA—prostate cancer	0.000223	0.00166	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERCC2—prostate cancer	0.000221	0.00164	CbGpPWpGaD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—prostate cancer	0.000219	0.00027	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Prednisone—prostate cancer	0.000219	0.00027	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—prostate cancer	0.000218	0.000268	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Prednisone—prostate cancer	0.000218	0.000268	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—prostate cancer	0.000217	0.000267	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Etoposide—prostate cancer	0.000216	0.000266	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ERBB3—prostate cancer	0.000216	0.00161	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGFR2—prostate cancer	0.000215	0.0016	CbGpPWpGaD
Gadopentetate dimeglumine—Anorexia—Docetaxel—prostate cancer	0.000215	0.000265	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Prednisone—prostate cancer	0.000215	0.000265	CcSEcCtD
Gadopentetate dimeglumine—Shock—Capecitabine—prostate cancer	0.000215	0.000265	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—prostate cancer	0.000215	0.000264	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—COMT—prostate cancer	0.000215	0.0016	CbGpPWpGaD
Gadopentetate dimeglumine—Abdominal pain—Etoposide—prostate cancer	0.000215	0.000264	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Etoposide—prostate cancer	0.000215	0.000264	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—prostate cancer	0.000215	0.000264	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Capecitabine—prostate cancer	0.000214	0.000264	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Prednisone—prostate cancer	0.000214	0.000263	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—GSTP1—prostate cancer	0.000214	0.00159	CbGpPWpGaD
Gadopentetate dimeglumine—Tachycardia—Capecitabine—prostate cancer	0.000213	0.000262	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Capecitabine—prostate cancer	0.000212	0.000261	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—prostate cancer	0.000212	0.000261	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—prostate cancer	0.000212	0.00026	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Capecitabine—prostate cancer	0.000211	0.00026	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—prostate cancer	0.000211	0.00026	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—prostate cancer	0.000211	0.00026	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—prostate cancer	0.000211	0.000259	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ITPR1—prostate cancer	0.00021	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—prostate cancer	0.00021	0.000259	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Prednisone—prostate cancer	0.00021	0.000258	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000209	0.000257	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Capecitabine—prostate cancer	0.000208	0.000256	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Estradiol—prostate cancer	0.000208	0.000256	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Mitoxantrone—prostate cancer	0.000208	0.000255	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MTHFR—prostate cancer	0.000207	0.00154	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TERT—prostate cancer	0.000207	0.00154	CbGpPWpGaD
Gadopentetate dimeglumine—Convulsion—Prednisone—prostate cancer	0.000207	0.000254	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—prostate cancer	0.000207	0.000254	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Prednisone—prostate cancer	0.000206	0.000253	CcSEcCtD
Gadopentetate dimeglumine—Rash—Mitoxantrone—prostate cancer	0.000206	0.000253	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Mitoxantrone—prostate cancer	0.000206	0.000253	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000206	0.000253	CcSEcCtD
Gadopentetate dimeglumine—Headache—Mitoxantrone—prostate cancer	0.000205	0.000252	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Capecitabine—prostate cancer	0.000204	0.000251	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Prednisone—prostate cancer	0.000203	0.00025	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—prostate cancer	0.000203	0.000249	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—prostate cancer	0.000203	0.000249	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Prednisone—prostate cancer	0.000202	0.000249	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—prostate cancer	0.000202	0.000248	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000202	0.000248	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—prostate cancer	0.000201	0.000248	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—prostate cancer	0.000201	0.000247	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—prostate cancer	0.0002	0.000246	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Etoposide—prostate cancer	0.0002	0.000246	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—prostate cancer	0.0002	0.000246	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000199	0.000245	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—prostate cancer	0.000199	0.000245	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—prostate cancer	0.000199	0.000245	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—prostate cancer	0.000199	0.000245	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—TYMS—prostate cancer	0.000199	0.00148	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIF1A—prostate cancer	0.000198	0.00147	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM1—prostate cancer	0.000196	0.00146	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Capecitabine—prostate cancer	0.000196	0.000241	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—prostate cancer	0.000196	0.000241	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—prostate cancer	0.000196	0.000241	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Etoposide—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Capecitabine—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisone—prostate cancer	0.000195	0.00024	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—prostate cancer	0.000195	0.000239	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—prostate cancer	0.000194	0.000239	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—prostate cancer	0.000194	0.000239	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Mitoxantrone—prostate cancer	0.000194	0.000239	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—prostate cancer	0.000194	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—prostate cancer	0.000193	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—prostate cancer	0.000193	0.000238	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—prostate cancer	0.000193	0.000238	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—LPL—prostate cancer	0.000193	0.00144	CbGpPWpGaD
Gadopentetate dimeglumine—Chills—Epirubicin—prostate cancer	0.000192	0.000237	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Etoposide—prostate cancer	0.000192	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisone—prostate cancer	0.000192	0.000236	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—prostate cancer	0.000191	0.000236	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CAV1—prostate cancer	0.000191	0.00142	CbGpPWpGaD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—prostate cancer	0.000191	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Prednisone—prostate cancer	0.000191	0.000235	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisone—prostate cancer	0.00019	0.000234	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Capecitabine—prostate cancer	0.00019	0.000234	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Prednisone—prostate cancer	0.000189	0.000233	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000189	0.000232	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Capecitabine—prostate cancer	0.000188	0.000232	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisone—prostate cancer	0.000188	0.000232	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—prostate cancer	0.000188	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—prostate cancer	0.000188	0.000231	CcSEcCtD
Gadopentetate dimeglumine—Pain—Capecitabine—prostate cancer	0.000187	0.00023	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Capecitabine—prostate cancer	0.000187	0.00023	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—prostate cancer	0.000187	0.00023	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1A1—prostate cancer	0.000186	0.00139	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—prostate cancer	0.000186	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Etoposide—prostate cancer	0.000186	0.000229	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Prednisone—prostate cancer	0.000186	0.000228	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—prostate cancer	0.000185	0.000228	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—prostate cancer	0.000185	0.000228	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ERCC2—prostate cancer	0.000185	0.00138	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000185	0.000227	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—prostate cancer	0.000184	0.000226	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—prostate cancer	0.000184	0.000226	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—prostate cancer	0.000183	0.000225	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—prostate cancer	0.000183	0.000225	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—prostate cancer	0.00018	0.000222	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Capecitabine—prostate cancer	0.00018	0.000222	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—prostate cancer	0.00018	0.000221	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—BAD—prostate cancer	0.00018	0.00134	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Etoposide—prostate cancer	0.00018	0.000221	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—prostate cancer	0.000179	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000179	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—prostate cancer	0.000179	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—prostate cancer	0.000178	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—prostate cancer	0.000178	0.00022	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—prostate cancer	0.000178	0.000219	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000177	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—prostate cancer	0.000177	0.000218	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisone—prostate cancer	0.000175	0.000215	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—APC—prostate cancer	0.000174	0.0013	CbGpPWpGaD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—prostate cancer	0.000174	0.000214	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Capecitabine—prostate cancer	0.000174	0.000214	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—MTHFR—prostate cancer	0.000174	0.00129	CbGpPWpGaD
Gadopentetate dimeglumine—Abdominal pain—Capecitabine—prostate cancer	0.000173	0.000213	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Capecitabine—prostate cancer	0.000173	0.000213	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Etoposide—prostate cancer	0.000173	0.000213	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—prostate cancer	0.000173	0.000212	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IRS1—prostate cancer	0.000172	0.00128	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGF—prostate cancer	0.000172	0.00128	CbGpPWpGaD
Gadopentetate dimeglumine—Agitation—Epirubicin—prostate cancer	0.000171	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Rash—Etoposide—prostate cancer	0.000171	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Etoposide—prostate cancer	0.000171	0.000211	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PPARA—prostate cancer	0.00017	0.00127	CbGpPWpGaD
Gadopentetate dimeglumine—Headache—Etoposide—prostate cancer	0.00017	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—prostate cancer	0.000169	0.000208	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Prednisone—prostate cancer	0.000169	0.000208	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—prostate cancer	0.000169	0.000208	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—prostate cancer	0.000168	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Prednisone—prostate cancer	0.000168	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—prostate cancer	0.000167	0.000206	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—GSK3B—prostate cancer	0.000167	0.00125	CbGpPWpGaD
Gadopentetate dimeglumine—Back pain—Doxorubicin—prostate cancer	0.000167	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Prednisone—prostate cancer	0.000166	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—prostate cancer	0.000166	0.000205	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—INS—prostate cancer	0.000165	0.00123	CbGpPWpGaD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—prostate cancer	0.000164	0.000202	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—prostate cancer	0.000163	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—prostate cancer	0.000162	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—prostate cancer	0.000162	0.000199	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CREBBP—prostate cancer	0.000161	0.0012	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Etoposide—prostate cancer	0.000161	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—prostate cancer	0.000161	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Capecitabine—prostate cancer	0.000161	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisone—prostate cancer	0.00016	0.000197	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CAV1—prostate cancer	0.00016	0.00119	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Docetaxel—prostate cancer	0.00016	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Prednisone—prostate cancer	0.000159	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—prostate cancer	0.000159	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—prostate cancer	0.000159	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—prostate cancer	0.000159	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—prostate cancer	0.000158	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000158	0.000194	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Capecitabine—prostate cancer	0.000157	0.000193	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—prostate cancer	0.000156	0.000192	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—prostate cancer	0.000155	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—prostate cancer	0.000155	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisone—prostate cancer	0.000155	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Capecitabine—prostate cancer	0.000155	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—prostate cancer	0.000154	0.00019	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MAP2K1—prostate cancer	0.000154	0.00115	CbGpPWpGaD
Gadopentetate dimeglumine—Abdominal pain—Prednisone—prostate cancer	0.000154	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Prednisone—prostate cancer	0.000154	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—prostate cancer	0.000154	0.000189	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CD—prostate cancer	0.000153	0.00114	CbGpPWpGaD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—prostate cancer	0.000152	0.000187	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—prostate cancer	0.000152	0.000187	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SERPINE1—prostate cancer	0.000151	0.00113	CbGpPWpGaD
Gadopentetate dimeglumine—Cough—Doxorubicin—prostate cancer	0.000151	0.000185	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—prostate cancer	0.00015	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—prostate cancer	0.00015	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Capecitabine—prostate cancer	0.00015	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—prostate cancer	0.000149	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—prostate cancer	0.000149	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—prostate cancer	0.000149	0.000183	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—prostate cancer	0.000149	0.000183	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—prostate cancer	0.000148	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—prostate cancer	0.000147	0.000181	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—FGF2—prostate cancer	0.000147	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—prostate cancer	0.000146	0.00018	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000146	0.00018	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CG—prostate cancer	0.000146	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—Anorexia—Epirubicin—prostate cancer	0.000145	0.000179	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—NOS3—prostate cancer	0.000145	0.00108	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Capecitabine—prostate cancer	0.000145	0.000178	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—prostate cancer	0.000144	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—prostate cancer	0.000144	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisone—prostate cancer	0.000143	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—prostate cancer	0.000142	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—prostate cancer	0.000142	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—prostate cancer	0.000142	0.000175	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—prostate cancer	0.000141	0.000174	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000141	0.000173	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—JAK2—prostate cancer	0.000141	0.00105	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Prednisone—prostate cancer	0.00014	0.000172	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Capecitabine—prostate cancer	0.000139	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000139	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—prostate cancer	0.000139	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—prostate cancer	0.000138	0.00017	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—INS—prostate cancer	0.000138	0.00103	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Capecitabine—prostate cancer	0.000138	0.00017	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Prednisone—prostate cancer	0.000138	0.000169	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Capecitabine—prostate cancer	0.000138	0.000169	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—prostate cancer	0.000138	0.000169	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MDM2—prostate cancer	0.000137	0.00102	CbGpPWpGaD
Gadopentetate dimeglumine—Headache—Capecitabine—prostate cancer	0.000137	0.000168	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—prostate cancer	0.000137	0.000168	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—prostate cancer	0.000137	0.000168	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000136	0.000168	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—prostate cancer	0.000136	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—prostate cancer	0.000135	0.000167	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CREBBP—prostate cancer	0.000135	0.00101	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB2—prostate cancer	0.000135	0.00101	CbGpPWpGaD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—prostate cancer	0.000134	0.000165	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—prostate cancer	0.000134	0.000165	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CB—prostate cancer	0.000133	0.000994	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Prednisone—prostate cancer	0.000133	0.000164	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—prostate cancer	0.000132	0.000163	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—prostate cancer	0.000132	0.000985	CbGpPWpGaD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—prostate cancer	0.000132	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000131	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—prostate cancer	0.000131	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—prostate cancer	0.00013	0.00016	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—prostate cancer	0.00013	0.00016	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Capecitabine—prostate cancer	0.00013	0.00016	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisone—prostate cancer	0.000129	0.000158	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000128	0.000158	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CD—prostate cancer	0.000128	0.000955	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—prostate cancer	0.000127	0.000156	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—prostate cancer	0.000126	0.000155	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—prostate cancer	0.000125	0.000154	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—prostate cancer	0.000125	0.000154	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN1B—prostate cancer	0.000125	0.000933	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000125	0.000153	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Prednisone—prostate cancer	0.000124	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisone—prostate cancer	0.000123	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisone—prostate cancer	0.000123	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—prostate cancer	0.000122	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisone—prostate cancer	0.000122	0.00015	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000122	0.00015	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—prostate cancer	0.000121	0.000149	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—NOS3—prostate cancer	0.000121	0.000902	CbGpPWpGaD
Gadopentetate dimeglumine—Urticaria—Epirubicin—prostate cancer	0.000121	0.000149	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—prostate cancer	0.00012	0.000148	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CTNNB1—prostate cancer	0.000118	0.000881	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—prostate cancer	0.000116	0.000143	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisone—prostate cancer	0.000116	0.000142	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN1A—prostate cancer	0.000116	0.000861	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTEN—prostate cancer	0.000115	0.000859	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000115	0.000142	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—prostate cancer	0.000112	0.000138	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—prostate cancer	0.000112	0.000138	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CB—prostate cancer	0.000112	0.000833	CbGpPWpGaD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—prostate cancer	0.000111	0.000137	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—prostate cancer	0.000111	0.000137	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—prostate cancer	0.000111	0.000825	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EP300—prostate cancer	0.00011	0.000819	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Epirubicin—prostate cancer	0.000109	0.000134	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—prostate cancer	0.000108	0.000133	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SRC—prostate cancer	0.000107	0.000797	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—prostate cancer	0.000104	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—prostate cancer	0.000104	0.000128	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—STAT3—prostate cancer	0.000103	0.000768	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—prostate cancer	0.000101	0.000124	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—prostate cancer	9.97e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—prostate cancer	9.68e-05	0.000119	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PTEN—prostate cancer	9.66e-05	0.00072	CbGpPWpGaD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—prostate cancer	9.64e-05	0.000119	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—prostate cancer	9.6e-05	0.000118	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—prostate cancer	9.59e-05	0.000118	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MYC—prostate cancer	9.58e-05	0.000714	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFB1—prostate cancer	9.56e-05	0.000712	CbGpPWpGaD
Gadopentetate dimeglumine—Headache—Epirubicin—prostate cancer	9.54e-05	0.000117	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—EGFR—prostate cancer	9.37e-05	0.000698	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—prostate cancer	9.32e-05	0.000115	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—EP300—prostate cancer	9.21e-05	0.000686	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Epirubicin—prostate cancer	9.04e-05	0.000111	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—prostate cancer	8.96e-05	0.00011	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—prostate cancer	8.88e-05	0.000109	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—prostate cancer	8.88e-05	0.000109	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—KRAS—prostate cancer	8.85e-05	0.00066	CbGpPWpGaD
Gadopentetate dimeglumine—Headache—Doxorubicin—prostate cancer	8.83e-05	0.000109	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—prostate cancer	8.37e-05	0.000103	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CA—prostate cancer	8.13e-05	0.000606	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL6—prostate cancer	7.2e-05	0.000537	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CA—prostate cancer	6.81e-05	0.000508	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT1—prostate cancer	6.65e-05	0.000495	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKT1—prostate cancer	5.57e-05	0.000415	CbGpPWpGaD
